Rehmann Capital Advisory Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Sell |
5,146
-145
| -3% | -$12K | 0.03% | 386 |
|
|
2025
Q1 | $429K | Hold |
5,291
| – | – | 0.03% | 393 |
|
|
2024
Q4 | $477K | Buy |
5,291
+345
| +7% | +$31.1K | 0.03% | 361 |
|
|
2024
Q3 | $489K | Hold |
4,946
| – | – | 0.03% | 342 |
|
|
2024
Q2 | $459K | Buy |
4,946
+2,356
| +91% | +$218K | 0.03% | 342 |
|
|
2024
Q1 | $246K | Buy |
+2,590
| New | +$246K | 0.02% | 505 |
|
|
2021
Q4 | – | Sell |
-2,205
| Closed | -$277K | – | 591 |
|
|
2021
Q3 | $277K | Hold |
2,205
| – | – | 0.03% | 454 |
|
|
2021
Q2 | $299K | Buy |
2,205
+280
| +15% | +$37.9K | 0.03% | 432 |
|
|
2021
Q1 | $261K | Buy |
+1,925
| New | +$261K | 0.03% | 441 |
|
|
2019
Q3 | – | Sell |
-929
| Closed | -$81.5K | – | 2158 |
|
|
2019
Q2 | $81.5K | Sell |
929
-14
| -1% | -$1.23K | 0.01% | 677 |
|
|
2019
Q1 | $85.3K | Sell |
943
-74,454
| -99% | -$6.74M | 0.01% | 642 |
|
|
2018
Q4 | $2.8M | Buy |
75,397
+73,962
| +5,154% | +$2.74M | 0.42% | 30 |
|
|
2018
Q3 | $138K | Buy |
1,435
+356
| +33% | +$34.1K | 0.02% | 500 |
|
|
2018
Q2 | $103K | Buy |
1,079
+300
| +39% | +$28.6K | 0.01% | 558 |
|
|
2018
Q1 | $68K | Buy |
+779
| New | +$68K | 0.01% | 661 |
|